M

Monte Rosa Therapeutics Inc
NASDAQ:GLUE

Watchlist Manager
Monte Rosa Therapeutics Inc
NASDAQ:GLUE
Watchlist
Price: 6.93 USD 6.45% Market Closed
Market Cap: 425.8m USD
Have any thoughts about
Monte Rosa Therapeutics Inc?
Write Note

Wall Street
Price Targets

GLUE Price Targets Summary
Monte Rosa Therapeutics Inc

Wall Street analysts forecast GLUE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLUE is 16.76 USD with a low forecast of 14.14 USD and a high forecast of 21 USD.

Lowest
Price Target
14.14 USD
104% Upside
Average
Price Target
16.76 USD
142% Upside
Highest
Price Target
21 USD
203% Upside
Monte Rosa Therapeutics Inc Competitors:
Price Targets
VCEL
Vericel Corp
9% Upside
INSM
Insmed Inc
29% Upside
VTGN
VistaGen Therapeutics Inc
430% Upside
SWTX
SpringWorks Therapeutics Inc
92% Upside
TNGX
Tango Therapeutics Inc
278% Upside
006280
Green Cross Corp
15% Upside
IDYA
IDEAYA Biosciences Inc
118% Upside
KTRA
Kintara Therapeutics Inc
143% Upside

Revenue
Forecast

Revenue Estimate
Monte Rosa Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Monte Rosa Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Monte Rosa Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GLUE's stock price target?
Price Target
16.76 USD

According to Wall Street analysts, the average 1-year price target for GLUE is 16.76 USD with a low forecast of 14.14 USD and a high forecast of 21 USD.

Back to Top